Viewing nowOstem Esomeprazole 20mg Tablets (Esomeprazole Magnesium Trihydrate)
Esomeprazole Magnesium Dihydrate 21.69mg
Tablet · Prescription medication
Ostem Pharma Co., Ltd.

MFDS item code 202006602 · Approved 2020.09.24 · Insurance code 053500210
Treatment and prevention of reflux and excess stomach acid, ulcers (including eradication therapy and prevention of rebleeding), and gastrointestinal disorders caused by anti-inflammatory analgesics
This medicine is used to treat various symptoms and diseases related to gastroesophageal reflux disease. It is effective for the treatment and prevention of erosive reflux esophagitis, as well as for the relief of symptoms associated with gastroesophageal reflux disease without esophagitis. It also helps treat and prevent recurrence of duodenal ulcers and peptic ulcers caused by Helicobacter pylori infection. It is used to relieve gastrointestinal symptoms associated with NSAID use as well as for the treatment and prevention of related gastric and duodenal ulcers. It is utilized in the treatment of Zollinger-Ellison syndrome and for the maintenance therapy to prevent rebleeding from gastric or duodenal ulcers. This drug is used for the treatment and symptom improvement of various gastrointestinal diseases.
This medicine should be swallowed with a liquid such as water and must not be chewed or crushed. Treatment of erosive reflux esophagitis: 40 mg once daily for 4 weeks. Patients whose esophagitis has not healed or whose symptoms persist should take the medicine for an additional 4 weeks. Long-term maintenance therapy to prevent recurrence in patients with esophagitis: 20 mg once daily Symptomatic treatment of gastroesophageal reflux disease without esophagitis: 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is required. Once symptoms have resolved, subsequent symptoms may be controlled by administering 20 mg once daily. In adults, 20 mg may be administered once daily as needed. As-needed administration is not recommended for controlling recurring symptoms in patients at high risk of developing gastric and duodenal ulcers due to nonsteroidal anti-inflammatory drug use. Administer this medicine 20 mg in combination with amoxicillin 1 g and clarithromycin 500 mg twice daily for 7 days. Short-term treatment of upper gastrointestinal symptoms (pain, discomfort, burning sensation) associated with nonsteroidal anti-inflammatory drug use (nonselective or selective COX-2): 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is required. Clinical studies exceeding 4 weeks have not been conducted. Treatment of gastric ulcers associated with nonsteroidal anti-inflammatory drug use: 20 mg once daily. The treatment period is 4∼8 weeks. Prevention of gastric and duodenal ulcers associated with nonsteroidal anti-inflammatory drug use: 20 mg once daily. Treatment of Zollinger-Ellison syndrome: The recommended initial dose is 40 mg twice daily. The dose should then be adjusted individually, and treatment should continue while clinical symptoms are present. Clinical data indicate that most patients can be controlled with doses of 80 ∼ 160 mg daily. Doses exceeding 80 mg per day should be divided into 2 doses. After induction of prevention of rebleeding from gastric or duodenal ulcers with intravenous administration, administer 40 mg once daily for 4 weeks. Renal impairment: No dose adjustment is necessary. Use with caution because experience in patients with severe renal impairment is limited. Hepatic impairment: No dose adjustment is necessary in patients with mild to moderate hepatic impairment. In patients with severe hepatic impairment, the dose of this medicine should not exceed 20 mg. Elderly patients: No dose adjustment is necessary.
Adolescents aged 12 years and older — Treatment of erosive reflux esophagitis: 40 mg once daily for 4 weeks. Patients whose esophagitis has not healed or whose symptoms persist should take the medicine for an additional 4 weeks. Adolescents aged 12 years and older — Symptomatic treatment of gastroesophageal reflux disease without esophagitis: 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is required. Adolescents aged 12 years and older — Once symptoms have resolved, subsequent symptoms may be controlled by administering 20 mg once daily. Adolescents aged 12 years and older — In adults, 20 mg may be administered once daily as needed. As-needed administration is not recommended for controlling recurring symptoms in patients at high risk of developing gastric and duodenal ulcers due to nonsteroidal anti-inflammatory drug use. Children under 12 years — There is no experience with administration of this medicine to children under 12 years of age.
This medication should not be administered to individuals with known allergies or hypersensitivity to any of its components. Caution is particularly needed when taken in combination with certain antibiotics or antiviral medications as side effects or drug interactions may occur. Pregnant or nursing women, as well as individuals with a history of heart disease, are advised against taking this medication. Also, those with allergic reactions to any colorants included in this medication should use it cautiously. Rarely, various side effects such as blood abnormalities, allergic reactions, neurological symptoms, gastrointestinal disorders, liver function abnormalities, and skin rashes may occur while taking this medication. Regular check-ups are needed for long-term use, and any changes in symptoms should be discussed with a physician. This medication can lower stomach acid, which might promote bacterial growth in the gastrointestinal tract, thus slightly increasing the risk of gastrointestinal infections. Long-term high-dose use may increase the risk of fractures, so patients at risk for osteoporosis should be cautious. Additionally, it may cause decreased magnesium levels, so magnesium levels in the blood should be regularly monitored during long-term use. This medication may interact with other drugs, so it is essential to inform your doctor or pharmacist about any other medications you are taking. Caution should be exercised when using this medication during pregnancy, and it is safest to avoid it while breastfeeding. In cases of overdose, there is no specific antidote available, so appropriate treatment should be provided according to symptoms. This medication should be kept out of reach of children and should not be transferred to another container.
Leukopenia, thrombocytopenia, agranulocytosis, pancytopenia, fever, angioedema, anaphylactic reaction, shock, peripheral edema, hyponatremia, hypomagnesemia, insomnia, anxiety, mental confusion, depression, aggression, hallucination, headache, dizziness, paresthesia, drowsiness, taste disturbance, blurred vision, bronchospasm, pancreatitis, abdominal pain, constipation, diarrhea, abdominal bloating, nausea, vomiting, dry mouth, stomatitis, gastrointestinal candidiasis, microscopic colitis, increased liver enzymes, jaundice, hepatitis, liver failure, encephalopathy, dermatitis, itching, rash, urticaria, hair loss, photosensitivity, erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis, Lyle syndrome, acute generalized pustular psoriasis, eosinophilia with systemic symptoms drug reaction, fracture, arthralgia, myalgia, muscle weakness, interstitial nephritis, gynecomastia, myasthenia, increased sweating, Clostridium difficile diarrhea, abdominal bloating, allergic reaction, back pain, chest pain, sternal pain, facial edema, facial flushing, fatigue, influenza-like illness, generalized edema, leg edema, lethargy, pain, stiffness, peripheral edema, flushing, hypertension, tachycardia, thyroid nodule, irritable bowel syndrome, worsening of constipation, dyspepsia, dysphagia, gastrointestinal malformation, upper abdominal pain, belching, esophageal disorder, frequent bowel movements, gastroenteritis, gastrointestinal bleeding, hiccups, melena, oral disorders, pharyngeal disorders, rectal disorders, gastrointestinal symptoms, increased blood gastrin, tongue disorders, tongue swelling, ulcerative stomatitis, vomiting, ear pain, tinnitus, anemia, hypopigmented anemia, cervical lymphadenopathy, epistaxis, leukocytosis, leukopenia, thrombocytopenia, hyperbilirubinemia, liver dysfunction, increased ALT, increased AST, diabetes, hyperuricemia, increased ALP, thirst, vitamin B12 deficiency, weight gain, weight loss, worsening of arthritis, joint disease, convulsions, fibromyalgia syndrome, hernia, rheumatic polymyalgia, arthralgia, loss of appetite, apathy, increased appetite, confusion, worsening of depression, hypertonicity, anxiety, sensory loss, erectile dysfunction, insomnia, migraine, worsening of migraine, sleep disorders, tremor, dizziness, visual field loss, paresthesia, drowsiness, dysmenorrhea, menstrual disorders, vaginitis, worsening of asthma, cough, dyspnea, laryngeal edema, pharyngitis, rhinitis, sinusitis, acne, anal itching, rash, erythematous rash, papular rash, angioedema, dermatitis, itching, urticaria, increased sweating, otitis media, abnormal olfaction, taste loss, taste distortion, urinary abnormalities, albuminuria, cystitis, dysuria, fungal infection, hematuria, urinary frequency, candidiasis, genital candidiasis, polyuria, conjunctivitis, visual disturbances, duodenitis, esophagitis, esophageal stricture, esophageal ulcer, esophageal varices, gastric ulcer, gastritis, benign polyp or nodule, Barrett's esophagus, mucosal discoloration, hernia, systemic lupus erythematosus, cutaneous lupus erythematosus, hypocalcemia, hypokalemia, rhabdomyolysis
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air and moisture, so it should be stored in a tightly closed container. It is recommended to maintain the storage temperature between 1 and 30 degrees Celsius at room temperature to preserve the medication's effectiveness for a longer period.
Pale pink rectangular film-coated tablet
28 tablets/box [(14 tablets/Alu-Alu * 2)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowEsomeprazole Magnesium Dihydrate 21.69mg
Tablet · Prescription medication
Ostem Pharma Co., Ltd.

Esomeprazole Magnesium Trihydrate 44.5mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Esomeprazole Magnesium Trihydrate 44.5mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Esomeprazole Magnesium Dihydrate 43.38mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Esomeprazole Magnesium Dihydrate 21.69mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
Samjin Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.